Stocks
Kezar Technologies IncorporatedKZAR
HealthcareBiotechnology
A clinical-stage biotechnology company developing novel therapies for autoimmune and inflammatory diseases. Its lead candidate targets a validated pathway with potential to address significant unmet medical need. Investors track KZAR for its pipeline progress and upcoming clinical data readouts.
Congressional Interest in Kezar Technologies Incorporated (KZAR)
1 member of Congress has disclosed 1 trade in Kezar Technologies Incorporated (KZAR), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading KZAR?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-05-07 | JAMES B. RENACCI | buy | $1K-$15K |